HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...

Mike Francisco was an athletic 35-year-old Phoenix medical professional when he was diagnosed with late-stage colon cancer. His story is not unusual.

Over 20 years, researchers tracked diet and health in more than 5,000 adults over 80 — and found a striking difference in one ...

Longevity is being framed as a consumer movement when, in reality, it is a pharmaceutical pipeline challenge. And pharma isn’t treating it like one yet.

Symptoms that were once quietly endured or dismissed as something women simply had to “get on with” are now being discussed openly in workplaces, GP surgeries and across the media. More women are ...